Literature DB >> 2341194

A contiguous network of dendritic antigen-presenting cells within the respiratory epithelium.

P G Holt1, M A Schon-Hegrad, J Oliver, B J Holt, P G McMenamin.   

Abstract

This study utilises a simple technique to section airway epithelium in a plane parallel to the basement membrane, thus providing a unique plan view of the intra-epithelial cell populations. Immunoperoxidase staining of these tissue sections for class II major histocompatibility complex Ia antigen reveals a virtually contiguous network of Ia-positive dendritic cells (DC) within the epithelium. These DC are shown to be capable of binding inhaled antigens in vivo in a form suitable for presentation to T cells. The strategic location of these cells and the fact that they account for virtually all staining in the airway epithelium during the steady state is convincing evidence that the DC network functions as the 'first line of defence' in surveillance for inhaled antigens and further suggests a major role for the intra-epithelial DC in allergic and infectious disease(s) in the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341194     DOI: 10.1159/000235107

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  35 in total

Review 1.  Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.

Authors:  Ralph Marvin Steinman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

2.  Single dose intranasal administration of retinal autoantigen generates a rapid accumulation and cell activation in draining lymph node and spleen: implications for tolerance therapy.

Authors:  A D Dick; V Sharma; J Liversidge
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

3.  Steroids inhibit uptake and/or processing but not presentation of antigen by airway dendritic cells.

Authors:  P G Holt; J A Thomas
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

4.  Diesel exhaust particle-treated human bronchial epithelial cells upregulate Jagged-1 and OX40 ligand in myeloid dendritic cells via thymic stromal lymphopoietin.

Authors:  Bertram Bleck; Doris B Tse; Terry Gordon; Mohammad R Ahsan; Joan Reibman
Journal:  J Immunol       Date:  2010-10-25       Impact factor: 5.422

5.  Activation of pulmonary dendritic cells and Th2-type inflammatory responses on instillation of engineered, environmental diesel emission source or ambient air pollutant particles in vivo.

Authors:  Gillina F G Bezemer; Stephen M Bauer; Günter Oberdörster; Patrick N Breysse; Raymond H H Pieters; Steve N Georas; Marc A Williams
Journal:  J Innate Immun       Date:  2010-11-23       Impact factor: 7.349

6.  An investigation of the impact of the location and timing of antigen-specific T cell division on airways inflammation.

Authors:  S Hutchison; B S W Choo-Kang; V B Gibson; R V Bundick; A J Leishman; J M Brewer; I B McInnes; P Garside
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 7.  Chemokines and their receptors in the allergic airway inflammatory process.

Authors:  Juan Raymundo Velazquez; Luis Manuel Teran
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

8.  CARMA3 Is Critical for the Initiation of Allergic Airway Inflammation.

Authors:  Benjamin Causton; Ravisankar A Ramadas; Josalyn L Cho; Khristianna Jones; Ana Pardo-Saganta; Jayaraj Rajagopal; Ramnik J Xavier; Benjamin D Medoff
Journal:  J Immunol       Date:  2015-06-03       Impact factor: 5.422

Review 9.  Cell and molecular biology of chemical allergy.

Authors:  I Kimber; R J Dearman
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

10.  Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells.

Authors:  Melissa Victoria Fernandez; Elizabeth Miller; Florian Krammer; Ramya Gopal; Benjamin D Greenbaum; Nina Bhardwaj
Journal:  J Leukoc Biol       Date:  2015-11-16       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.